NIT
CYTK icon

NumerixS Investment Technologies’s Cytokinetics CYTK Stock Holding History

NumerixS Investment Technologies’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-17,200
Closed -$140K – 1088
2017
Q4 		$140K Buy
+17,200
New +$195K 0.03% 571
2017
Q3 		– Sell
-100
Closed -$1K – 1191
2017
Q2 		$1K Buy
+100
New +$1.39K ﹤0.01% 1095

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

NumerixS Investment Technologies's CYTK Position: Q1 2018 in Review

NumerixS Investment Technologies sold out of Cytokinetics (CYTK) in Q1 2018, closing a stake of 17,200 shares — an estimated $140K sold.

NumerixS Investment Technologies first reported a position in CYTK in Q2 2017 and held it in 2 quarters. The position peaked at $140K in Q4 2017. 127 funds tracked by Wall St. Rank hold CYTK as of Q1 2018.

  • NumerixS Investment Technologies reported no remaining Cytokinetics position as of Q1 2018 after selling out during the quarter.
  • NumerixS Investment Technologies sold 17,200 Cytokinetics shares in Q1 2018, an estimated $140K.
  • NumerixS Investment Technologies first reported a position in Cytokinetics in Q2 2017 and held it in 2 quarters.
  • NumerixS Investment Technologies's Cytokinetics position peaked at $140K in Q4 2017.
  • 127 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2018.

Based on NumerixS Investment Technologies's 13F filing for Q1 2018, filed 14 May 2018.